Stonebridge Capital Management Trimmed By $490,875 Its Palo Alto Networks Com (PANW) Holding; Last Week Spectrum Pharmaceuticals, Inc. (SPPI) Analysts

June 20, 2018 - By Adrian Mccoy

Palo Alto Networks, Inc. (NYSE:PANW) Logo

Among 6 analysts covering Spectrum Pharma (NASDAQ:SPPI), 6 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Spectrum Pharma had 14 analyst reports since August 7, 2015 according to SRatingsIntel. The stock of Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) has “Buy” rating given on Monday, October 9 by Jefferies. FBR Capital maintained the stock with “Buy” rating in Tuesday, April 10 report. The stock of Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) earned “Buy” rating by FBR Capital on Monday, May 14. RBC Capital Markets maintained the shares of SPPI in report on Thursday, November 5 with “Outperform” rating. H.C. Wainwright reinitiated Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) rating on Wednesday, August 16. H.C. Wainwright has “Buy” rating and $14 target. The company was maintained on Wednesday, June 7 by Jefferies. H.C. Wainwright maintained Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) rating on Friday, May 4. H.C. Wainwright has “Buy” rating and $3300 target. The firm has “Buy” rating given on Friday, February 10 by Jefferies. RBC Capital Markets maintained Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) rating on Friday, August 7. RBC Capital Markets has “Outperform” rating and $13 target. The rating was maintained by Jefferies on Thursday, August 24 with “Buy”. See Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) latest ratings:

14/05/2018 Broker: FBR Capital Rating: Buy New Target: $26.0000 Maintain
04/05/2018 Broker: H.C. Wainwright Rating: Buy New Target: $33.0000 Maintain
10/04/2018 Broker: FBR Capital Rating: Buy New Target: $26.0000 Maintain

Stonebridge Capital Management Inc decreased Palo Alto Networks Inc Com (PANW) stake by 51.22% reported in 2018Q1 SEC filing. Stonebridge Capital Management Inc sold 2,625 shares as Palo Alto Networks Inc Com (PANW)’s stock rose 23.61%. The Stonebridge Capital Management Inc holds 2,500 shares with $468,000 value, down from 5,125 last quarter. Palo Alto Networks Inc Com now has $19.60B valuation. The stock decreased 0.41% or $0.87 during the last trading session, reaching $210.97. About 991,627 shares traded. Palo Alto Networks, Inc. (NYSE:PANW) has risen 77.91% since June 20, 2017 and is uptrending. It has outperformed by 65.34% the S&P500. Some Historical PANW News: ; 22/04/2018 – DJ Palo Alto Networks Inc, Inst Holders, 1Q 2018 (PANW); 23/05/2018 – UKRAINE STATE SECURITY SERVICE SAYS THE POSSIBLE CYBER ATTACK APPEARS TO BE FOCUSED ON UKRAINE; 04/05/2018 – The Famous Soccer Player Hiding Out in a Bakery in Palo Alto; 23/04/2018 – Light Street’s Kacher Touts Palo Alto Networks at Sohn: TOPLive; 05/04/2018 – Cohesity Hires Enterprise Technology Veteran Matt McSweeney as Vice President of Sales, Americas; 11/04/2018 – Luminate Announces General Availability of Its BeyondCorp-as-a-Service Secured Access Platform; 26/03/2018 – Palo Alto Networks Closes Acquisition Of Evident.Io; 23/04/2018 – LIGHT STREET’S KACHER PITCHES PALO ALTO NETWORKS LONNG AT SOHN; 16/05/2018 – OPAQ Networks to Co-Present Session with Channel Partner on Security-as-a-Service at Palo Alto Ignite `18 USA; 20/03/2018 – PALO ALTO NETWORKS ANNOUNCES ADVANCEMENTS TO ITS TRAPS ADVANCED ENDPOINT PROTECTION OFFERING

Since March 21, 2018, it had 0 insider purchases, and 25 selling transactions for $18.63 million activity. $78,884 worth of stock was sold by Turgeon Joseph W. on Wednesday, March 28. 90,000 shares were sold by SHROTRIYA RAJESH C MD, worth $1.47M. Another trade for 220 shares valued at $3,830 was sold by Riga Thomas J. GUSTAFSON KURT A had sold 1,300 shares worth $22,594 on Monday, March 26. 9,275 shares were sold by COHEN RAYMOND W, worth $169,918. Krassner Stuart Mitchell also sold $78,278 worth of Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) on Wednesday, March 21.

The stock increased 0.35% or $0.07 during the last trading session, reaching $19.96. About 1.69 million shares traded or 2.23% up from the average. Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) has risen 216.89% since June 20, 2017 and is uptrending. It has outperformed by 204.32% the S&P500. Some Historical SPPI News: ; 10/04/2018 – SPECTRUM PHARMACEUTICALS REPORTS UPDATE OF MD ANDERSON DATA; 15/03/2018 – ONXEO SA C4X.PA – ASIDNA INDUCED HIGH POTENTIATION OF BELINOSTAT ACTIVITY ON ITS TARGETS; 07/03/2018 – Delcath Announces Commercial Supply Agreement for Melphalan Hydrochloride for Injection with Tillomed Laboratories; 17/04/2018 – SPPI: DATA SHOWS POZIOTINIB OVERCOMES RESISTANCE OF MUTATIONS; 16/05/2018 – SPECTRUM PHARMA REPORTS RESULTS FROM PHASE 3 STUDY OF ROLONTIS; 03/05/2018 – SPECTRUM GETS LICENSE TO FILED PATENTS RELATED TO EXON 20; 03/04/2018 – Spectrum Pharma Presenting at Conference Apr 10; 03/05/2018 – SPECTRUM PHARMA 1Q LOSS/SHR 16C, EST. LOSS/SHR 34C; 06/03/2018 – SPECTRUM PHARMACEUTICALS INC SPPI.O SEES FY 2018 REVENUE $90 MLN TO $110 MLN; 03/04/2018 – Spectrum Pharmaceuticals to Present Corporate Update at the H.C. Wainwright Global Life Sciences Conference on April 10th

Investors sentiment decreased to 1.18 in Q1 2018. Its down 0.45, from 1.63 in 2017Q4. It turned negative, as 19 investors sold Spectrum Pharmaceuticals, Inc. shares while 43 reduced holdings. 26 funds opened positions while 47 raised stakes. 79.34 million shares or 1.43% more from 78.22 million shares in 2017Q4 were reported. Northern Corp holds 0% or 1.08 million shares. Principal Financial Group accumulated 721,337 shares. Massmutual Tru Fsb Adv has invested 0% in Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI). Jpmorgan Chase & Com has invested 0% of its portfolio in Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI). Virtu Financial Ltd Liability Com holds 0.02% of its portfolio in Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) for 17,906 shares. Riverhead Capital Mngmt Limited Liability owns 8,700 shares. Invesco Ltd accumulated 1.22 million shares. Ameritas Investment Prtnrs reported 0.01% in Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI). Dekabank Deutsche Girozentrale holds 69,400 shares or 0.01% of its portfolio. Amalgamated Comml Bank invested in 0.01% or 12,277 shares. Alliancebernstein Limited Partnership accumulated 121,675 shares. State Board Of Administration Of Florida Retirement Sys stated it has 0% of its portfolio in Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI). Piermont, a Missouri-based fund reported 90,352 shares. Balyasny Asset Mgmt Ltd Liability Co holds 383,423 shares. Arizona State Retirement Sys has 142,970 shares for 0.02% of their portfolio.

Spectrum Pharmaceuticals, Inc. develops and commercializes oncology and hematology drug products. The company has market cap of $2.06 billion. The firm markets six drug products, including FUSILEV for patients with metastatic colorectal cancer and rescue after high-dose methotrexate therapy in osteosarcoma, and to diminish toxicity and counteract the effects of impaired methotrexate elimination and of inadvertent overdosage of folic acid antagonists; FOLOTYN, a folate analogue metabolic inhibitor to treat patients with relapsed or refractory PTCL; ZEVALIN injection for patients with follicular non-HodgkinÂ’s lymphoma; MARQIBO, a sphingomyelin/cholesterol liposome-encapsulated formulation for adult patients with Philadelphia chromosome-negative acute lymphoblastic leukemia; BELEODAQ injection for patients with relapsed or refractory PTCL; and EVOMELA for use as a conditioning treatment prior to autologous stem cell transplant in multiple myeloma patients. It currently has negative earnings. It is also developing ROLONTIS for chemotherapy-induced neutropenia; QAPZOLA for intravesical instillation in post-transurethral resection of bladder tumors in patients with non-muscle invasive bladder cancer; and POZIOTINIB for treating breast and lung cancer.

Stonebridge Capital Management Inc increased Merck & Company (NYSE:MRK) stake by 10,509 shares to 70,153 valued at $4.01 million in 2018Q1. It also upped Exxon Mobil Corporation (NYSE:XOM) stake by 6,183 shares and now owns 112,692 shares. Baker Hughes A Ge Co Cl A was raised too.

Investors sentiment decreased to 1.18 in 2018 Q1. Its down 0.04, from 1.22 in 2017Q4. It turned negative, as 43 investors sold PANW shares while 172 reduced holdings. 89 funds opened positions while 165 raised stakes. 72.18 million shares or 1.82% more from 70.89 million shares in 2017Q4 were reported. Moreover, Columbia Asset has 0.06% invested in Palo Alto Networks, Inc. (NYSE:PANW). Emerald Advisers Pa holds 9,440 shares or 0.07% of its portfolio. Alphaone Invest Services Limited Company invested 0.01% of its portfolio in Palo Alto Networks, Inc. (NYSE:PANW). Pitcairn stated it has 3,980 shares or 0.08% of all its holdings. Tennessee-based Ftb Advsrs has invested 0.03% in Palo Alto Networks, Inc. (NYSE:PANW). Kingdon Ltd Liability stated it has 64,663 shares or 0.93% of all its holdings. Voya Invest Mgmt Limited Liability Company owns 1.65M shares. Middleton & Communications Ma reported 0.15% in Palo Alto Networks, Inc. (NYSE:PANW). Swiss Bank accumulated 294,800 shares or 0.07% of the stock. North Star holds 150 shares or 0% of its portfolio. Amer & Mngmt holds 175 shares or 0.01% of its portfolio. Bancorp Hapoalim Bm holds 0.09% of its portfolio in Palo Alto Networks, Inc. (NYSE:PANW) for 1,830 shares. The California-based Schwab Charles Mngmt has invested 0.03% in Palo Alto Networks, Inc. (NYSE:PANW). Cwm Limited Co owns 0% invested in Palo Alto Networks, Inc. (NYSE:PANW) for 327 shares. Mackay Shields Ltd Limited Liability Company has 0.04% invested in Palo Alto Networks, Inc. (NYSE:PANW).

Among 53 analysts covering Palo Alto Networks (NYSE:PANW), 43 have Buy rating, 2 Sell and 8 Hold. Therefore 81% are positive. Palo Alto Networks had 220 analyst reports since July 22, 2015 according to SRatingsIntel. The company was maintained on Wednesday, May 30 by Stifel Nicolaus. As per Monday, September 12, the company rating was initiated by Rosenblatt. Needham maintained the shares of PANW in report on Thursday, September 10 with “Buy” rating. The firm has “Buy” rating by Northland Capital given on Tuesday, February 27. On Wednesday, August 31 the stock rating was maintained by Barclays Capital with “Overweight”. Deutsche Bank downgraded it to “Hold” rating and $150 target in Friday, May 27 report. The stock of Palo Alto Networks, Inc. (NYSE:PANW) earned “Buy” rating by Wunderlich on Wednesday, August 31. Needham maintained the stock with “Buy” rating in Friday, February 26 report. The rating was maintained by Northland Capital with “Buy” on Friday, September 1. The rating was upgraded by Evercore on Thursday, January 18 to “Buy”.

Since January 2, 2018, it had 2 buys, and 20 sales for $63.30 million activity. Shares for $373,709 were sold by MERESMAN STANLEY J on Tuesday, March 13. 5,818 Palo Alto Networks, Inc. (NYSE:PANW) shares with value of $1.16M were sold by Bonanno Kathleen. Shares for $5.45M were sold by ZUK NIR on Tuesday, March 6. The insider MCLAUGHLIN MARK D sold $9.93 million. Klarich Lee sold 8,894 shares worth $1.80M. BONVANIE RENE sold $2.69M worth of Palo Alto Networks, Inc. (NYSE:PANW) on Monday, June 11. Shares for $5.98 million were sold by Anderson Mark.

More notable recent Palo Alto Networks, Inc. (NYSE:PANW) news were published by: Finance.Yahoo.com which released: “How Financially Strong Is Palo Alto Networks Inc (NYSE:PANW)?” on June 04, 2018, also Seekingalpha.com with their article: “Palo Alto Networks: Acceleration Kicks In” published on June 05, 2018, Streetinsider.com published: “Oppenheimer Reiterates Outperform on Palo Alto Networks (PANW) Following Investor Meetings” on June 18, 2018. More interesting news about Palo Alto Networks, Inc. (NYSE:PANW) were released by: Seekingalpha.com and their article: “Palo Alto Networks Back In The Market’s Good Graces, And Outperformance Is Getting Harder” published on June 07, 2018 as well as Gurufocus.com‘s news article titled: “Palo Alto Networks Inc (PANW) CEO Nikesh Arora Bought $13.4 million of Shares” with publication date: June 15, 2018.

Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) Institutional Positions Chart

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>